Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hoppe

Showing results (131-140 of 287) with videos related to

Pageof 29
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 31, 2013
Hip fractures and pain following proton therapy for management of prostate cancerRaul Valery, Nancy P Mendenhall, Romaine C Nichols, et al.
Clinical Lung Cancer|January 24, 2012
Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early resultsBradford S Hoppe, Stella Flampouri, Randal H Henderson, et al.
Practical Radiation Oncology|October 6, 2019
The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiation Therapy EraBradford S Hoppe, James E Bates, Nancy P Mendenhall, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 2008
Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk?Bradford S Hoppe, Benjamin Laser, Alex V Kowalski, et al.
Acta Oncologica (Stockholm, Sweden)|May 19, 2017
Five-year outcomes from a prospective trial of image-guided accelerated hypofractionated proton therapy for prostate cancerRandal H Henderson, Curtis Bryant, Bradford S Hoppe, et al.
American Journal of Clinical Oncology|April 9, 2014
Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?Curtis Bryant, Nancy P Mendenhall, Randal H Henderson, et al.
Acta Oncologica (Stockholm, Sweden)|February 27, 2013
Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancerRovel J Colaco, Soon Huh, Romaine C Nichols, et al.
International Journal of Radiation Oncology, Biology, Physics|November 25, 2010
Early outcomes from three prospective trials of image-guided proton therapy for prostate cancerNancy P Mendenhall, Zuofeng Li, Bradford S Hoppe, et al.
Journal of Gastrointestinal Oncology|February 4, 2014
Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancerRovel J Colaco, Romaine Charles Nichols, Soon Huh, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2007
Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experienceDaniel R Gomez, Bradford S Hoppe, Suzanne L Wolden, et al.
Pageof 29

Showing results (131-140 of 287) with videos related to

Sort By:
Pageof 29
Acta Oncologica (Stockholm, Sweden)|January 31, 2013
Hip fractures and pain following proton therapy for management of prostate cancerRaul Valery, Nancy P Mendenhall, Romaine C Nichols, et al.
Clinical Lung Cancer|January 24, 2012
Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early resultsBradford S Hoppe, Stella Flampouri, Randal H Henderson, et al.
Practical Radiation Oncology|October 6, 2019
The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiation Therapy EraBradford S Hoppe, James E Bates, Nancy P Mendenhall, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 2008
Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk?Bradford S Hoppe, Benjamin Laser, Alex V Kowalski, et al.
Acta Oncologica (Stockholm, Sweden)|May 19, 2017
Five-year outcomes from a prospective trial of image-guided accelerated hypofractionated proton therapy for prostate cancerRandal H Henderson, Curtis Bryant, Bradford S Hoppe, et al.
American Journal of Clinical Oncology|April 9, 2014
Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?Curtis Bryant, Nancy P Mendenhall, Randal H Henderson, et al.
Acta Oncologica (Stockholm, Sweden)|February 27, 2013
Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancerRovel J Colaco, Soon Huh, Romaine C Nichols, et al.
International Journal of Radiation Oncology, Biology, Physics|November 25, 2010
Early outcomes from three prospective trials of image-guided proton therapy for prostate cancerNancy P Mendenhall, Zuofeng Li, Bradford S Hoppe, et al.
Journal of Gastrointestinal Oncology|February 4, 2014
Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancerRovel J Colaco, Romaine Charles Nichols, Soon Huh, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2007
Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experienceDaniel R Gomez, Bradford S Hoppe, Suzanne L Wolden, et al.
Pageof 29